While unstimulated CLL cells derived from peripheral blood had low death receptor expression, CD40L stimulation upregulated Fas and TRAIL-R2 (but not TRAIL-R1) as well as “decoy” receptors TRAIL-R3/4 in CLL cells (Figure 3A-3B). The gene discussed is FAS; the disease is B-cell chronic lymphocytic leukemia.